760-834-7949

Current Clinical Trials

UNDER EVALUATION: Depemokimab as an Extended treatmeNt DURation biologic in Adults with • COPD and type 2 inflammation ENDURA-1/ENDURA-2
  1. Rancho Mirage, CA
  2. Accepting new patients

Description

Summary

A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation. Protocol title: ENDURA-1/ENDURA-2: A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation.

Official Title

UNDER EVALUATION: A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation. Protocol title: ENDURA-1/ENDURA-2: A randomized, double-blind, placebo-controlled, parallel-group, multicenter study of the efficacy and safety of depemokimab in adult participants with COPD with Type 2 inflammation.

Keywords

COPD

Lead Scientist at Eisenhower Health

Clinical Study Details

  1. Accepting new patients
  4. Interventional
  5. June 17, 2026